FI861045A - B-laktamantibiotika, foerfarande foer deras framstaellning och deras anvaendning som laekemedel. - Google Patents

B-laktamantibiotika, foerfarande foer deras framstaellning och deras anvaendning som laekemedel. Download PDF

Info

Publication number
FI861045A
FI861045A FI861045A FI861045A FI861045A FI 861045 A FI861045 A FI 861045A FI 861045 A FI861045 A FI 861045A FI 861045 A FI861045 A FI 861045A FI 861045 A FI861045 A FI 861045A
Authority
FI
Finland
Prior art keywords
deras
lactamantibiotics
image
foerfarande foer
framstaellning och
Prior art date
Application number
FI861045A
Other languages
English (en)
Other versions
FI85025C (fi
FI85025B (fi
FI861045A0 (fi
Inventor
Gunter Schmidt
Hans-Joachim Zeiler
Karl Georg Metzger
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of FI861045A0 publication Critical patent/FI861045A0/fi
Publication of FI861045A publication Critical patent/FI861045A/fi
Application granted granted Critical
Publication of FI85025B publication Critical patent/FI85025B/fi
Publication of FI85025C publication Critical patent/FI85025C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36—Methylene radicals, substituted by sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/21—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D499/44—Compounds with an amino radical acylated by carboxylic acids, attached in position 6
    • C07D499/48—Compounds with an amino radical acylated by carboxylic acids, attached in position 6 with a carbon chain, substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, attached to the carboxamido radical
    • C07D499/58—Compounds with an amino radical acylated by carboxylic acids, attached in position 6 with a carbon chain, substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, attached to the carboxamido radical substituted in alpha-position to the carboxamido radical
    • C07D499/64—Compounds with an amino radical acylated by carboxylic acids, attached in position 6 with a carbon chain, substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, attached to the carboxamido radical substituted in alpha-position to the carboxamido radical by nitrogen atoms
    • C07D499/70—Compounds with an amino radical acylated by carboxylic acids, attached in position 6 with a carbon chain, substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, attached to the carboxamido radical substituted in alpha-position to the carboxamido radical by nitrogen atoms with hetero rings as additional substituents on the carbon chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/22—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/59—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3 with hetero atoms directly attached in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI861045A 1985-03-16 1986-03-13 Foerfarande foer framstaellning av nya -laktamantibiotika. FI85025C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19853509618 DE3509618A1 (de) 1985-03-16 1985-03-16 Ss-lactam-antibiotika, verfahren zur herstellung und ihre verwendung als arzneimittel
DE3509618 1985-03-16

Publications (4)

Publication Number Publication Date
FI861045A0 FI861045A0 (fi) 1986-03-13
FI861045A true FI861045A (fi) 1986-09-17
FI85025B FI85025B (fi) 1991-11-15
FI85025C FI85025C (fi) 1992-02-25

Family

ID=6265496

Family Applications (1)

Application Number Title Priority Date Filing Date
FI861045A FI85025C (fi) 1985-03-16 1986-03-13 Foerfarande foer framstaellning av nya -laktamantibiotika.

Country Status (19)

Country Link
US (1) US4734407A (fi)
EP (1) EP0197294B1 (fi)
JP (1) JPS61215395A (fi)
KR (1) KR860007268A (fi)
CN (1) CN1015262B (fi)
AT (1) ATE62245T1 (fi)
AU (1) AU589950B2 (fi)
CA (1) CA1280408C (fi)
DD (1) DD246993A5 (fi)
DE (2) DE3509618A1 (fi)
DK (1) DK118386A (fi)
ES (1) ES8705452A1 (fi)
FI (1) FI85025C (fi)
GR (1) GR860708B (fi)
HU (1) HU195663B (fi)
IL (1) IL78137A (fi)
NO (1) NO860726L (fi)
PT (1) PT82203B (fi)
ZA (1) ZA861915B (fi)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3713872A1 (de) * 1987-04-25 1988-11-17 Hoechst Ag Substituierte chinoxalyl-imidazolidin-2,4-dione, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel sowie pharmazeutische praeparate
US5171854A (en) * 1987-05-26 1992-12-15 Bayer Aktiengesellschaft Substituted vinylcephalosporins
DE3733626A1 (de) * 1987-10-05 1989-04-13 Bayer Ag Heteroanellierte phenylglycin-(beta)-lactam-antibiotika, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE3803169A1 (de) * 1988-02-03 1989-08-17 Bayer Ag Ss-lactam-antibiotika, verfahren zu ihrer herstellung und ihre verwendung als und in arzneimitteln
US5114929A (en) * 1989-03-21 1992-05-19 Beecham Group P.L.C. Pharmaceutical formulation
DE4411657A1 (de) * 1994-04-02 1995-10-05 Basf Ag Verfahren zur Herstellung von 6-Hydroxymethylchinolinen
DE4443892A1 (de) * 1994-12-09 1996-06-13 Bayer Ag 4-(Chinolin-2-yl-methoxy)-phenyl-essigsäurederivate
TW200902008A (en) * 2007-05-10 2009-01-16 Smithkline Beecham Corp Quinoxaline derivatives as PI3 kinase inhibitors
EP2280601A4 (en) * 2008-02-21 2012-08-29 Sequoia Pharmaceuticals Inc AMINO ACID HEMMER OF CYTOCHROM P450

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3080356A (en) * 1960-06-15 1963-03-05 Beecham Res Lab Process for the production of synthetic penicillins
SE302125B (fi) 1961-03-23 1968-07-08 Bristol Myers Co
GB1174335A (en) 1967-03-07 1969-12-17 Lilly Co Eli 7-Alpha-Amino-3-Methyl Cephalosporin Analogues, Pharmaceutical Compositions comprising the same and processes for preparing the same
ES401263A1 (es) 1972-03-28 1975-02-16 Beecham Group Ltd Un procedimiento para la produccion de alfa - amino-(p-hi- droxibencil) penicilina.
US3925372A (en) 1973-02-23 1975-12-09 Lilly Co Eli Alpha-aminoacyl-3-halo cephalosporins
YU36970B (en) 1973-02-23 1984-08-31 Lilly Co Eli Process for obtaining 7-(amino)-acylamido-3-halocephalosporins
IL52144A (en) 1976-07-01 1979-10-31 Lilly Co Eli De-esterification process for -lactam antibiotic esters
GB1546622A (en) 1976-12-09 1979-05-23 Beecham Group Ltd Bisnor penicillanic acid derivatives methods for their preparation and compositions containing
DE2831568C2 (de) * 1977-07-23 1985-01-10 Toyama Chemical Co. Ltd., Tokio / Tokyo 7α-Methoxycephalosporine und Verfahren zur Herstellung derselben
US4229575A (en) * 1978-02-27 1980-10-21 Richardson-Merrell Inc. 7-(2,3-Dihydrobenzo-5-furanyl)-acetamido cephalosporin derivatives
US4138397A (en) * 1978-02-27 1979-02-06 Richardson-Merrell Inc. 6-(2,3-Dihydro-5-benzofuranyl)acetamido penicillin derivatives
US4219648A (en) * 1978-03-06 1980-08-26 Richardson-Merrell Inc. 7-[[Amino(1,3-dihydrobenzo[c]thienyl)acetyl]amino]cephalosporin derivatives
US4461767A (en) * 1978-06-16 1984-07-24 E. R. Squibb & Sons, Inc. Iminothiazolyl ureido cephalosporins
US4317775A (en) * 1980-01-07 1982-03-02 Hoffmann-La Roche Inc. Amoxicillin derivatives
FR2511375A1 (fr) * 1981-08-17 1983-02-18 Rhone Poulenc Sante Nouveaux derives de la cephalosporine, leur preparation et les medicaments qui les contiennent
NZ203734A (en) * 1982-03-31 1986-03-14 Beecham Group Plc Beta-lactam derivatives and pharmaceutical compositions
EP0121499A3 (de) * 1983-03-31 1985-09-25 Ciba-Geigy Ag 7Beta-Acylamido-3-cephem-4-carbonsäureverbindungen, Verfahren zu ihrer Herstellung, pharmazeutische Präparate, welche diese Verbindungen enthalten, und Verwendung von letzteren
US4492694A (en) * 1983-04-12 1985-01-08 Eli Lilly And Company Indolylglycyl cephalosporin derivatives
US4501741A (en) * 1983-04-12 1985-02-26 Eli Lilly And Company Cephalosporin antibiotics
DE3508258A1 (de) * 1985-03-08 1986-09-18 Bayer Ag, 5090 Leverkusen Ss-lactamantibiotika, verfahren zur herstellung und ihre verwendung als und in arzneimitteln

Also Published As

Publication number Publication date
DK118386A (da) 1986-09-17
FI85025C (fi) 1992-02-25
CN1015262B (zh) 1992-01-01
CA1280408C (en) 1991-02-19
ES553033A0 (es) 1987-05-01
GR860708B (en) 1986-07-15
CN86101695A (zh) 1986-09-10
EP0197294A2 (de) 1986-10-15
DE3509618A1 (de) 1986-09-18
US4734407A (en) 1988-03-29
PT82203B (pt) 1988-07-29
EP0197294B1 (de) 1991-04-03
AU5472286A (en) 1986-09-18
IL78137A0 (en) 1986-07-31
FI85025B (fi) 1991-11-15
AU589950B2 (en) 1989-10-26
IL78137A (en) 1991-03-10
DE3678478D1 (de) 1991-05-08
NO860726L (no) 1986-09-17
DD246993A5 (de) 1987-06-24
ES8705452A1 (es) 1987-05-01
ATE62245T1 (de) 1991-04-15
ZA861915B (en) 1986-11-26
KR860007268A (ko) 1986-10-10
EP0197294A3 (en) 1988-05-04
FI861045A0 (fi) 1986-03-13
JPS61215395A (ja) 1986-09-25
DK118386D0 (da) 1986-03-14
HUT41032A (en) 1987-03-30
PT82203A (en) 1986-04-01
HU195663B (en) 1988-06-28

Similar Documents

Publication Publication Date Title
FI860945A (fi) ^-laktamantibiotika, foerfarande foer deras framstaellning och deras anvaendning som och i laekemedel.
ATE6422T1 (de) 3-aryloxy-3-phenylpropylamine.
FI853622A0 (fi) Diarylacetylener, deras framstaellning och anvaendning.
FI932104A (fi) Nya 4-arylpiperaziner och 4-arylpiperidiner
FI863836A (fi) Kinolinderivat.
FI861045A (fi) B-laktamantibiotika, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
ATE54306T1 (de) Aminoacrylsaeure-derivate.
FI882444A (fi) Substituerade vinylkefalosporiner, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
AU546025B2 (en) Agent for detecting ketone-bodies

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: BAYER AKTIENGESELLSCHAFT